In the present study, we show the first experimental evidence of a tumor suppressor role of BCL7A in vivo and in vitro in AML, finding that some tumors silence BCL7A expression by promoter methylation and presenting the first functional models that support its tumor suppressor role. This evidence concerns the gene BCL7A and acute myeloid leukemia.